Comparison of Traditional and Ultrasound-Guided Techniques for Vascular Access in Patients With Difficult Venous Access in Emergency Department.
Launched by MERCEDES SEGUNDA PERALTA GÁMEZ · Jun 2, 2025
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for accessing veins in patients who have difficult venous access in the emergency department. The researchers want to find out if using ultrasound technology can make it easier for nurses to insert needles into veins and arteries compared to the traditional method, which relies on feeling and seeing the veins. The study will look at factors like how many attempts are needed, how much time it takes, and how much discomfort patients feel during the procedure.
To be eligible for this trial, patients must have a doctor's order for a specific type of venous access and must be able to sign an informed consent form. This means that they or their representatives need to understand what the study is about and agree to participate. Patients who qualify will be part of a comparison between the two techniques, helping to improve care for others in the future. It's important to know that this study is currently recruiting participants, and it aims to provide valuable information that could enhance how vascular access is performed in emergency situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Prescription for CIP or GA cannulation.
- • Informed consent signed by the patient or patient's representative.
- • A score ≥3 on the A-DICAVE scale or ≥4 on the DIVA scale for PIVC.
- Exclusion Criteria:
- • Scores below 3 on the A-DICAVE scale or below 4 on the DIVA scale for PIVC.
- • Inability to obtain informed consent from the patient or patient's representative
About Mercedes Segunda Peralta Gámez
Mercedes Segunda Peralta Gámez is a dedicated clinical trial sponsor with a focus on advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a commitment to ethical standards and regulatory compliance, the organization collaborates with leading research institutions and healthcare professionals to conduct rigorous clinical studies. Their portfolio encompasses a diverse range of therapeutic areas, demonstrating a steadfast dedication to enhancing healthcare through evidence-based practices and cutting-edge technology. Driven by a passion for scientific excellence, Mercedes Segunda Peralta Gámez aims to contribute significantly to the future of medicine and the well-being of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
ávila, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported